Keyword: Ozempic (semaglutide)
Despite outcomes data that left analysts less-than-enthused, Eli Lilly's Trulicity scored the FDA's nod to lower CV risks in a first-ever approval.
Direct-to-consumer drug ads tend to strike a dissonant chord. However, fan and foe can count on one thing: Prescription DTC advertising is here to stay. The evidence? Surviving more than 20 years of numerous legal, regulatory and perception challenges on its way to becoming a $6 billion-plus annual industry.
As Novo gears up its Rybelsus rollout, the injectable form of the med, Ozempic, was the star in 2019, CEO Lars Jorgensen said in an interview.
Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.
Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.
Novo Nordisk has selected Philadelphia as the second U.S. city in its localized initiative to prevent Type 2 diabetes.
Novo Nordisk’s new reality series about Type 2 diabetes features comedian Billy Gardell.
After Novo Nordisk secures U.S. access for Rybelsus, it'll be time to go into "strike mode" with full promotion, its CEO said.
ICER concluded that Novo Nordisk's diabetes pill Rybelsus will be less cost-effective than Jardiance as an add-on therapy in type 2 diabetes.
